Serum free light chain assay in all patients with newly diagnosed plasma cell dyscrasias. The myeloma xi study showed a significant improvement in progressionfree survival from 28. Multiple myeloma is a form of cancer that affects bone marrow, the spongy soft tissue that lies within the hollow centre of some bones. Multiple myeloma mm is typically characterized by the neoplastic proliferation of plasma cells producing a monoclonal immunoglobulin. Pdf advances in the imaging and treatment of multiple myeloma have occurred over the past. The bone marrow microenvironment in myeloma includes osteoblasts obl, osteoclasts ocl, stromal cells, endothelial cells, and osteocytes. Multiple myeloma mm is a plasma cell malignancy in which monoclonal plasma cells proliferate in bone marrow, resulting in an overabundance of monoclonal paraprotein m protein, destruction of bone, and displacement of other hematopoietic cell lines. Multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions. Every year 1 percent of the people with mgus in the united states develop multiple myeloma. Get an overview of multiple myeloma and the latest key statistics in the us. Multiple myeloma mm is a plasma cell malignancy characterized by a high capacity to induce osteolytic bone lesions. The multiple myelomainduced bone destruction is a result of the increased activity of osteoclasts that occurs adjacent to multiple myeloma cells.
Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. A solitary bone plasmacytoma sbp arises from the plasma cells located in the bone marrow. New insights into the pathophysiology of multiple myeloma. Usually, the bones of the hands, feet, and lower parts of the arms and legs are not affected, preserving the function of these critical areas. Multiple myeloma hematology and oncology merck manuals.
Multiple myeloma is the second most common type of blood cancer after leukemia. Multiple myeloma is a cancer that develops in the bone marrow, the spongy tissue found in the center of most bones. The plasma cells proliferate in the bone marrow and can result in extensive skeletal destruction with osteolytic lesions, osteopenia, andor pathologic fractures. What is the pathophysiology of multiple myeloma mm.
Learn about the risk factors for multiple myeloma and what you might be able to do to help lower your risk. Myeloma cells inhibit your bodys ability to fight infections. Pathophysiology of osteoblast and bone formation inhibition in mm. Multiple myeloma and related disorders pathophysiology of blood.
The bone marrow produces red blood cells, which carry oxygen throughout the body. Pathophysiology and diagnosis of multiple myeloma jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor. Multiple myeloma is a malignancy of terminally differentiated plasma cells, and patients typically present with bone marrow infiltration of clonal plasma cells. What is the pathophysiology of solitary plasmacytoma. Find out how multiple myeloma is tested for, diagnosed, and staged. Myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Epidemiology and pathophysiology multiple myeloma accounts for 1. By far, the most important of these tumors is multiple myeloma, which is diagnosed. Pdf myeloma bone disease mbd is a devastating complication of multiple myeloma mm. Request pdf pathophysiology of multiple myeloma bone disease multiple myeloma is a plasma cell malignancy characterized by the frequent development of osteolytic bone lesions.
Abstract multiple myeloma accounts for approximately 10% of. Multiple myeloma mm is a bcell malignancy characterized by the clonal proliferation of. Pathophysiology of multiple myeloma bone disease request pdf. Myeloma most often grows in the marrow within the bones of the spine, skull, pelvis, rib cage, shoulders, and hips. Multiple myeloma can also affect your bones, leading to bone pain, thinning bones and broken bones. Multiple myeloma represents 2% of all new cancer diagnoses in the united.
More than 80% of mm patients suffer from destructive bony lesions, leading to pain, fractures, mobility issues. The mprotein monoclonal immunoglobulin protein produced by the malignant plasma cells is igg in about 55% of myeloma patients and iga in about 20%. Cellular interactions in the bone marrow microenvironment in myeloma bone disease. Multiple myeloma is a neoplastic plasmacell disorder that is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment, monoclonal protein in the blood or.
1612 1420 1439 1417 777 901 762 532 1162 813 706 1507 402 1022 1379 1013 82 1453 400 86 731 1110 287 677 1040 50 575 1126 837 694 77 586